Efficacy and Safety of MIN-101: A 12-Week Randomized, Double-Blind, Placebo-Controlled Trial of a New Drug in Development for the Treatment of Negative Symptoms in Schizophrenia-Reference-Cited by-同舟云学术

Efficacy and Safety of MIN-101: A 12-Week Randomized, Double-Blind, Placebo-Controlled Trial of a New Drug in Development for the Treatment of Negative Symptoms in Schizophrenia

Published:2017-12 Issue:12 Volume:174 Page:1195-1202
ISSN:0002-953X
Container-title:American Journal of Psychiatry
language:en
Short-container-title:AJP

Author:

Davidson Michael¹,Saoud Jay¹,Staner Corinne¹,Noel Nadine¹,Luthringer Elisabeth¹,Werner Sandra¹,Reilly Joseph¹,Schaffhauser Jean-Yves¹,Rabinowitz Jonathan¹,Weiser Mark¹,Luthringer Remy¹

Affiliation:

1. From the Department of Psychiatry, Tel Aviv University Sackler School of Medicine, Tel Aviv, Israel; PPRS Research, Rouffach, France; Minerva Neurosciences, Waltham, Mass.; and the Louis and Gabi Weisfeld School of Social Work, Faculty of Social Sciences, Bar Ilan University, Ramat Gan, Israel.

Publisher

American Psychiatric Association Publishing

Subject

Psychiatry and Mental health

Cited by 75 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Network intervention analysis indicates that roluperidone achieves its effect on negative symptoms of schizophrenia by targeting avolition;European Neuropsychopharmacology;2024-10

2. Prevalence of prominent and predominant negative symptoms across different criteria for negative symptom severity and minimal positive symptoms: A comparison of different criteria;Schizophrenia Research;2024-09

3. Advancements in Non-Dopaminergic Treatments for Schizophrenia: A Systematic Review of Pipeline Developments;Pharmacopsychiatry;2024-05-06

4. New Drug Treatments for Schizophrenia: A Review of Approaches to Target Circuit Dysfunction;Biological Psychiatry;2024-05

5. Persistent negative symptoms in young people at clinical high risk of psychosis treated with an Italian early intervention program: a longitudinal study;European Archives of Psychiatry and Clinical Neuroscience;2024-04-26